At this year’s PAINWeek, I had the pleasure of sitting with Dr. Harry Leider, Chief Medical Officer and Senior Vice President at Ameritox to talk about a study he was presenting at the conference, and to get his perspective on the PAINWeek experience.

The use of opioids has grown significantly over the past 20 years, and patients on long term opioid therapy need to be monitored closely. Part of this monitoring includes urine drug testing to ensure compliance with the medication and to rule...